tradmap

HIT Financials Health In Tech, Inc.

3 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 31.9% per year over the past 2 years.
  • Net income has grown faster than revenue (90.7% vs 31.9% per year).
Revenue & net income
$0 $17M $33M 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
0% 44% 88% 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $1 $1 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $4M $8M 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$3M $483762 $4M $0 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $33M $1M 62.8% 0.0% $8M
2024 $19M $670477 79.2% 0.0% $8M
2023 $19M 88.0% 0.0% $2M

Valuation over time

How the market has priced HIT against its own fundamentals since 2024-12 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 304.1 608.2 Dec '24 Mar '25 Jun '25 Sep '25 Dec '25 Mar '26 Jun '26
P/E
Price / sales (P/S)
0.0 10.5 20.9 Dec '24 Mar '25 Jun '25 Sep '25 Dec '25 Mar '26 Jun '26
P/S

Frequently asked questions

Is HIT growing its revenue and profit?

Over the past 2 years, Health In Tech, Inc.'s revenue has grown 31.9% per year, and net income grown 90.7% per year. These are computed facts, not advice.

How much debt does HIT have?

As of FY2025, Health In Tech, Inc. reported — of total debt against $8M of cash.

What is HIT's profit margin?

In FY2025, gross margin was 62.8%, operating margin —, and net margin 3.8%.

What is HIT's P/E ratio?

As of Jun '26, Health In Tech, Inc. traded at a price-to-earnings ratio of about 44.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.